MPH-MLR capsule/sprinkles produced highly comparable , biphasic profiles of plasma MPH concentrations characterized by rapid initial peak , followed by moderate decline until 5 hours postdose , and gradual increase until 7 hours postdose , culminating in an attenuated second peak .